{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:26:41Z","timestamp":1790486801348,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,5,27]],"date-time":"2008-05-27T00:00:00Z","timestamp":1211846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1038\/sj.bjc.6604392","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T13:51:40Z","timestamp":1211982700000},"page":"1781-1783","source":"Crossref","is-referenced-by-count":42,"title":["Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity"],"prefix":"10.1038","volume":"98","author":[{"given":"K J","family":"Wernli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Trentham-Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,27]]},"reference":[{"key":"BF6604392_CR1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1006\/pmed.2001.0945","volume":"33","author":"A Akhmedkhanov","year":"2001","unstructured":"Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Kato I, Koenig KL, Shore RE (2001) Aspirin and epithelial ovarian cancer. Prev Med 33: 682\u2013687","journal-title":"Prev Med"},{"key":"BF6604392_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1365-2125.2005.02386.x","volume":"60","author":"S Bonovas","year":"2005","unstructured":"Bonovas S, Filioussi K, Sitaras NM (2005) Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. Br J Clin Pharmacol 60: 194\u2013203","journal-title":"Br J Clin Pharmacol"},{"key":"BF6604392_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10552-006-0033-7","volume":"17","author":"C Bosetti","year":"2006","unstructured":"Bosetti C, Gallus S, La Vecchia C (2006) Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 17: 871\u2013888","journal-title":"Cancer Causes Control"},{"issue":"32","key":"BF6604392_CR4","first-page":"5","volume":"1","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I \u2013 the analysis of case\u2013control studies. IARC Sci Publ 1 (32): 5\u2013338","journal-title":"IARC Sci Publ"},{"key":"BF6604392_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47\u201355","journal-title":"JAMA"},{"key":"BF6604392_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(97)08064-1","volume":"351","author":"DW Cramer","year":"1998","unstructured":"Cramer DW, Harlow BL, Titus-Ernstoff L, Bohlke K, Welch WR, Greenberg ER (1998) Over-the-counter analgesics and risk of ovarian cancer. Lancet 351: 104\u2013107","journal-title":"Lancet"},{"key":"BF6604392_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1023\/A:1016380917625","volume":"13","author":"KM Fairfield","year":"2002","unstructured":"Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE (2002) Aspirin, other NSAIDs, and ovarian cancer risk (United States). Cancer Causes Control 13: 535\u2013542","journal-title":"Cancer Causes Control"},{"key":"BF6604392_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation \u2013 a factor in ovarian neoplasia? Lancet 2: 163","journal-title":"Lancet"},{"key":"BF6604392_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","volume":"247","author":"JS Fleming","year":"2006","unstructured":"Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247: 4\u201321","journal-title":"Mol Cell Endocrinol"},{"key":"BF6604392_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","volume":"88","author":"S Friis","year":"2003","unstructured":"Friis S, Sorensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH (2003) A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88: 684\u2013688","journal-title":"Br J Cancer"},{"key":"BF6604392_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ijc.11538","volume":"108","author":"JV Lacey Jr","year":"2004","unstructured":"Lacey Jr JV., Sherman ME, Hartge P, Schatzkin A, Schairer C (2004) Medication use and risk of ovarian carcinoma: a prospective study. Int J Cancer 108: 281\u2013286","journal-title":"Int J Cancer"},{"key":"BF6604392_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/pds.1134","volume":"15","author":"JD Lewis","year":"2006","unstructured":"Lewis JD, Strom BL, Kimmel SE, Farrar J, Metz DC, Brensinger C, Nessel L, Localio AR (2006) Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf 15: 39\u201345","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BF6604392_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1592\/phco.22.5.303.33189","volume":"22","author":"CR Meier","year":"2002","unstructured":"Meier CR, Schmitz S, Jick H (2002) Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 22: 303\u2013309","journal-title":"Pharmacotherapy"},{"key":"BF6604392_CR14","first-page":"903","volume":"10","author":"KB Moysich","year":"2001","unstructured":"Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H (2001) Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 10: 903\u2013906","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604392_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","volume":"91","author":"RB Ness","year":"1999","unstructured":"Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91: 1459\u20131467","journal-title":"J Natl Cancer Inst"},{"key":"BF6604392_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10552-005-0416-1","volume":"17","author":"NB Peterson","year":"2006","unstructured":"Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Gebretsadik T, Hampton JM, Stampfer MJ, Willett WC, Egan KM (2006) Relation of anthropometric measurements to ovarian cancer risk in a population-based case\u2013control study (United States). Cancer Causes Control 17: 459\u2013467","journal-title":"Cancer Causes Control"},{"key":"BF6604392_CR17","first-page":"933","volume":"9","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S (2000) A case\u2013control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9: 933\u2013937","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604392_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.ede.0000190538.55645.f8","volume":"17","author":"JM Schildkraut","year":"2006","unstructured":"Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A (2006) Analgesic drug use and risk of ovarian cancer. Epidemiology 17: 104\u2013107","journal-title":"Epidemiology"},{"key":"BF6604392_CR19","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","volume":"88","author":"HT Sorensen","year":"2003","unstructured":"Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA (2003) Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88: 1687\u20131692","journal-title":"Br J Cancer"},{"key":"BF6604392_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/1055-9965.EPI-06-0713","volume":"16","author":"BL Sprague","year":"2007","unstructured":"Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM (2007) Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev 16: 236\u2013243","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604392_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1023\/A:1008373616424","volume":"11","author":"A Tavani","year":"2000","unstructured":"Tavani A, Gallus S, La Vecchia C, Conti E, Montella M, Franceschi S (2000) Aspirin and ovarian cancer: an Italian case\u2013control study. Ann Oncol 11: 1171\u20131173","journal-title":"Ann Oncol"},{"key":"BF6604392_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","volume":"142","author":"SL West","year":"1995","unstructured":"West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A (1995) Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142: 1103\u20131112","journal-title":"Am J Epidemiol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604392","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:33:13Z","timestamp":1684413193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,27]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["BF6604392"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604392","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,27]]}}}